Macrophages and microcirculation in regressed and partially regressed irradiated choroidal and ciliary body melanomas

Current Eye Research

Volumn 27, Issue 4, 2003, Pages 237-245

  Toivonen, Päivi ^a   Mäkitie, Teemu ^a   Kujala, Emma ^a   Kivelä, Tero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Macrophages; Melanoma; Microcirculation; Radiation effects

Indexed keywords

CD68 ANTIGEN; EPITOPE; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CASE CONTROL STUDY; CHOROID MELANOMA; CILIARY BODY TUMOR; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITY; ENUCLEATION; EPITHELIOID CELL; EXTRAVASCULAR SPACE; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MICROCIRCULATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; RADIATION RESPONSE; STATISTICAL SIGNIFICANCE; TUMOR ASSOCIATED LEUKOCYTE;

BLOOD VESSELS; BRACHYTHERAPY; CASE-CONTROL STUDIES; CELL COUNT; CHOROID NEOPLASMS; CILIARY BODY; EYE ENUCLEATION; FEMALE; HUMANS; MACROPHAGES; MALE; MELANOMA; MICROCIRCULATION; NECROSIS; PIGMENTATION; UVEAL NEOPLASMS;

EID: 10744226571     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.27.4.237.16599     Document Type: Article

References (38)

1. Shields CL, Shields JA, Cater J, Gunduz K, Miyamoto C, Micaily B, Brady LW. Plaque radiotherapy for uveal melanoma: Long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol. 2000;118:1219-1228.
2. Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, Schachat AP, Straatsma BR, The Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS Report No. 18. Arch Ophthalmol. 2001;119:969-982.
3. Gunduz K, Shields CL, Shields JA, Cater J, Brady L. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Am J Ophthalmol. 2000;130:97-102.
4. Lommatzsch PK, Werschnik C, Schuster E. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 2000;238:129-137.
5. Liszauer AD, Brownstein S, Corriveau C, Deschenes J. A clinicopathological study of seven globes enucleated after primary radiation therapy for malignant melanoma of the choroid or ciliary body. Can J Ophthalmol. 1990;25:340-344.
6. Messmer E, Bornfeld N, Foerster M, Schilling H, Wessing A. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 1992;230:391-396.
7. Schilling H, Sehu KW, Lee WR. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques. Invest Ophthalmol Vis Sci. 1997;38:2081-2092.
8. Manschot WA, van Strik R. Uveal melanoma: Therapeutic consequences of doubling times and irradiation results; a review. Int Ophthalmol. 1992;16:91-99.
9. Eskelin S, Pyrhönen S, Summanen P, Hahka-Kemppinen M, Kivelä T. Tumor doubling times in metastatic malignant melanoma of the uvea: Tumor progression before and after treatment. Ophthalmology. 2000;107:1443-1449.
10. Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, Moninger TO, Yi H, Moore KC. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: A matched case-control study. Hum Pathol. 1992;23:1298-1305.
11. Seregard S, Spångberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology. 1998;105:485-491.
12. McLean IW, Keefe KS, Burnier MN. Uveal melanoma: comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology. 1997;104:777-780.
13. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst. 1999;91:359-367.
14. Foss AJE, Alexander RA, Jefferies LW, Hungerford JL, Harris AL, Lightman S. Microvessel count predicts survival in uveal melanoma. Cancer Res. 1996;56:2900-2903.
15. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 1999;40:2471-2480.
16. + cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42:1414-1421.
17. Mueller AJ, Freeman WR, Folberg R, Bartsch DU, Scheider A, Schaller U, Kampik A. Evaluation of microvascularization pattern visibility in human choroidal melanomas: Comparison of confocal fluorescein with indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol. 1999;237:448-456.
18. Schlesselman JJ. Case-control Studies: Design, Conduct, Analysis. New York: Oxford University Press, 1982.
19. Fuchs U, Kivelä T, Summanen P, Immonen I, Tarkkanen A. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma. Am J Pathol. 1992;141:169-181.
20. Burnier MJ, McLean IW, Gamel JW. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase. Cancer. 1991;68:809-814.
21. Steuhl KP, Rohrbach JM, Knorr M, Thiel HJ. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology. 1993;100:208-215.
22. Ramani P, Bradley NJ, Fletcher CDM. QBEND/10, a new monoclonal antibody to endothelium: Assessment of its diagnostic utility in paraffin sections. Histopathology. 1990;17:237-242.
23. Kivelä T. Immunohistochemical staining followed by bleaching of melanin: A practical method for ophthalmic pathology. Br J Biomed Sci. 1995;52:325-326.
24. Folberg R, Rummelt V, Parys-van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993;100:1389-1398.
25. Altman DG. Practical Statistics for Medical Research. 1st ed. London: Chapman & Hall, 1991.
26. Cuzick J. A Wilcoxon-type test for trend. Statistics in Medicine. 1985;4:87-90.
27. Lehmann EL. Nonparametrics: Statistical Methods Based on Ranks. San Francisco: Holden-Day, 1975.
28. Dithmar S, Rusciano D, Grossniklaus HE. A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma. Melanoma Res. 2000;10:2-8.
29. Apte RS, Niederkorn JY, Mayhew E, Alizadeh H. Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases. Arch Ophthalmol. 2001;119:1805-1809.
30. Chen X, Maniotis AJ, Majumdar D, Pe'er J, Folberg R. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci. 2002; 43:2533-2539.
31. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994;55:410-422.
32. Foss AJE, Alexander RA, Hungerford JL, Harris AL, Cree IA, Lightman S. Reassessment of the PAS patterns in uveal melanoma. Br J Ophthalmol. 1997;81:240-246.
33. Folberg R, Hendrix MJC, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000;156: 361-381.
34. Clarijs R, Otte-Holler I, Ruiter DJ, de Waal RM. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci. 2002;43:912-918.
35. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol. 2001;159:893-903.
36. Mueller AJ, Freeman WR, Schaller UC, Kampik A, Folberg R. Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology. 2002;109:2207-2214.
37. Seregard S, Lundell G, Lax I, Af TE, Kock E. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma. Acta Ophthalmol Scand. 1997;75:148-154.
38. Pe'er J, Stefani FH, Seregard S, Kivela T, Lommatzsch P, Prause JU, Sobottka B, Damato B, Chowers I. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: An EORTC Ocular Oncology Group study. Br J Ophthalmol. 2001;85:1208-1212.